Boston Scientific Scores Big Win In Patent Dispute
A federal appeals court gave Boston Scientific Corporation the green light to take a bite out of the multi-billion dollar U.S. market for drug-coated coronary stents last week when it affirmed...To view the full article, register now.
Already a subscriber? Click here to view full article